{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:42:35Z","timestamp":1759333355243},"reference-count":194,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Systemic sclerosis (SSc) is a complex autoimmune disorder that occurs in a genetically susceptible host. Genetic studies of SSc in recent years have defined or suggested a number of new genes with polymorphisms conferring susceptibility to or protection against SSc.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Although not all genes fall neatly into one functional category, the major genes with polymorphisms associated with SSc are those involved in immune regulation and inflammation, especially T-cell differentiation, proliferation, activation, B-cell signaling, and innate immunity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Understanding the functions of SSc-associated genes will provide important new insights in future studies to explore the pathogenesis of SSc, as well as to develop targeted therapies for SSc.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000334","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T16:48:46Z","timestamp":1471366126000},"page":"595-605","source":"Crossref","is-referenced-by-count":5,"title":["Multiple genes, especially immune-regulating genes, contribute to disease susceptibility in systemic sclerosis"],"prefix":"10.1097","volume":"28","author":[{"given":"Yunqing","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA"},{"name":"Department of Internal Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230829","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2249.1999.00990.x","article-title":"Systemic sclerosis: an autoantibody mosaic","volume":"117","author":"Bunn","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2133.1986.tb06233.x","article-title":"Scl 70 antibody \u2013 a specific marker of systemic sclerosis","volume":"115","author":"Jarzabek-Chorzelska","year":"1986","journal-title":"Br J Dermatol"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.77.3.1627","article-title":"Autoantibody to centromere (kinetochore) in scleroderma sera","volume":"77","author":"Moroi","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","article-title":"Incidence and prevalence of systemic sclerosis: a systematic literature review","volume":"37","author":"Chifflot","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/art.1780390814","article-title":"Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies","volume":"48","author":"Feghali-Bostwick","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa067655","article-title":"A polymorphism in the CTGF promoter region associated with systemic sclerosis","volume":"357","author":"Fonseca","year":"2007","journal-title":"N Engl J Med"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1136\/ard.2008.100180","article-title":"A large multicenter analysis of CTGF \u2212945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype","volume":"68","author":"Rueda","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.23601","article-title":"The PTPN22620W allele confers susceptibility to systemic sclerosis: findings of a large case\u2013control study of European Caucasians and a meta-analysis","volume":"58","author":"Dieud\u00e9","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/ard.2010.130138","article-title":"Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis","volume":"70","author":"Diaz-Gallo","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat Genet"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"e1002091","DOI":"10.1371\/journal.pgen.1002091","article-title":"Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis","volume":"7","author":"Allanore","year":"2011","journal-title":"PLoS Genet"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/ard.2009.111906","article-title":"Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls","volume":"69","author":"Arnett","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R17-20230829","first-page":"478","article-title":"Increased frequency of B8\/DR3 in scleroderma and association of the haplotype with impaired cellular immune response","volume":"43","author":"Kallenberg","year":"1981","journal-title":"Clin Exp Immunol"},{"key":"R18-20230829","first-page":"1481","article-title":"HLA markers for susceptibility and expression in scleroderma","volume":"32","author":"Gladman","year":"2005","journal-title":"J Rheumatol"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1399-0039.1992.tb01957.x","article-title":"HLA-DPB1 alleles and autoantibody subsets in systemic lupus erythematosus, Sj\u00f6gren's syndrome and progressive systemic sclerosis: a question of disease relevance","volume":"40","author":"Reveille","year":"1992","journal-title":"Tissue Antigens"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1874312901408010029","article-title":"Systemic sclerosis is a complex disease associated mainly with immune regulatory and inflammatory genes","volume":"8","author":"Jin","year":"2014","journal-title":"Open Rheumatol J"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.gene.6363734","article-title":"Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP","volume":"2","author":"Gilchrist","year":"2001","journal-title":"Genes Immun"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/art.24982","article-title":"HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans","volume":"60","author":"Zhou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"e87363","DOI":"10.1371\/journal.pone.0087363","article-title":"Association of HLA-DPB1 with scleroderma and its clinical features in Chinese population","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/sarh.2001.20268","article-title":"Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants","volume":"30","author":"Reveille","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2169\/internalmedicine.38.336","article-title":"Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis","volume":"38","author":"Kuwana","year":"1999","journal-title":"Intern Med"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/039463201302600318","article-title":"Association of HLA-DQB1\u22170501 with scleroderma and its clinical features in Chinese population","volume":"26","author":"Zhou","year":"2013","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.3899\/jrheum.090377","article-title":"Association of HLA class II genes with systemic sclerosis in Spanish patients","volume":"36","author":"Sime\u00f3n","year":"2009","journal-title":"J Rheumatol"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/rheumatology\/37.2.201","article-title":"HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients","volume":"37","author":"Fanning","year":"1998","journal-title":"Br J Rheumatol"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.0001-2815.2004.00199.x","article-title":"Human leukocyte antigen class II associations with systemic sclerosis in South Africans","volume":"63","author":"Tikly","year":"2004","journal-title":"Tissue Antigens"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/rheumatology\/ker335","article-title":"Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis","volume":"51","author":"Beretta","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.177.4.1093","article-title":"Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain","volume":"177","author":"Irving","year":"1993","journal-title":"J Exp Med"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-8674(88)90533-8","article-title":"Failure to synthesize the T cell CD3-zeta chain: structure and function of a partial T cell receptor complex","volume":"52","author":"Sussman","year":"1988","journal-title":"Cell"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"e71629","DOI":"10.1371\/journal.pone.0071629","article-title":"Down regulation of T cell receptor expression in COPD pulmonary CD8 cells","volume":"8","author":"Grundy","year":"2013","journal-title":"PLoS ONE"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nri1434","article-title":"TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response","volume":"4","author":"Baniyash","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/ni975","article-title":"Sustained exposure to bacterial antigen induces interferon-gamma-dependent T cell receptor zeta down-regulation and impaired T cell function","volume":"4","author":"Bronstein-Sitton","year":"2003","journal-title":"Nat Immunol"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4049\/jimmunol.180.2.1060","article-title":"Polymorphisms in the CD3Z gene influence TCRzeta expression in systemic lupus erythematosus patients and healthy controls","volume":"180","author":"Gorman","year":"2008","journal-title":"J Immunol"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1136\/ard.2010.147009","article-title":"Independent replication establishes the CD247 gene as a genetic systemic sclerosis susceptibility factor","volume":"70","author":"Dieud\u00e9","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/1874312901408010043","article-title":"Lack of association of the CD247 SNP rs2056626 with systemic sclerosis in Han Chinese","volume":"8","author":"Wang","year":"2014","journal-title":"Open Rheumatol J"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1517\/14728222.2014.920325","article-title":"Therapeutic potential of STAT4 in autoimmunity","volume":"18","author":"Liang","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1385\/IR:31:3:231","article-title":"STAT4: a critical regulator of inflammation in vivo","volume":"31","author":"Kaplan","year":"2005","journal-title":"Immunol Res"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1073\/pnas.92.16.7307","article-title":"Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes","volume":"92","author":"Bacon","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.0105-2896.2004.00211.x","article-title":"Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4","volume":"202","author":"Watford","year":"2004","journal-title":"Immunol Rev"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddp119","article-title":"The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype","volume":"18","author":"Rueda","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R44-20230829","first-page":"111","article-title":"Cytokine network in psoriasis. Cross-talk between keratinocytes and cells","volume":"31","author":"Wojas-Pelc","year":"2006","journal-title":"Centr Eur J Immunol"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12974-015-0351-3","article-title":"STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE","volume":"12","author":"McWilliams","year":"2015","journal-title":"J Neuroinflammation"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/039463201302600220","article-title":"STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population","volume":"26","author":"Yi","year":"2013","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/art.24688","article-title":"STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis","volume":"60","author":"Dieud\u00e9","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1002\/art.24958","article-title":"Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1\/Th2 cytokines","volume":"60","author":"Gourh","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.4049\/jimmunol.164.9.4659","article-title":"STAT4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation","volume":"164","author":"Frucht","year":"2000","journal-title":"J Immunol"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-\u03b3: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease","volume":"27","author":"Masters","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"R53-20230829","first-page":"997","article-title":"Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis","volume":"34","author":"Mattuzzi","year":"2007","journal-title":"J Rheumatol"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.it.2015.10.003","article-title":"Interleukin-2: biology, design and application","volume":"36","author":"Arenas-Ramirez","year":"2015","journal-title":"Trends Immunol"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jaci.2009.02.011","article-title":"IL-2- and CD25-dependentimmunoregulatory mechanisms in the homeostasis of T-cell subsets","volume":"123","author":"L\u00e9tourneau","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/annrheumdis-2012-202357","article-title":"Implication of IL-2\/IL-21 region in systemic sclerosis genetic susceptibility","volume":"72","author":"Diaz-Gallo","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"R58-20230829","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.icb.7100114","article-title":"Autoimmunity: IL-21: a new player in Th17-cell differentiation","volume":"85","author":"Deenick","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/art.20883","article-title":"Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis","volume":"52","author":"Distler","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/gene.2011.72","article-title":"The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis","volume":"13","author":"Martin","year":"2012","journal-title":"Genes Immun"},{"key":"R61-20230829","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R62-20230829","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1073\/pnas.82.16.5490","article-title":"Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2)","volume":"82","author":"Hirano","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R63-20230829","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"R64-20230829","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"key":"R65-20230829","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1038\/onc.2012.517","article-title":"Non-canonical Notch signaling activates IL-6\/JAK\/STAT signaling in breast tumor cells and is controlled by p53 and IKK\u03b1\/IKK\u03b2","volume":"32","author":"Jin","year":"2013","journal-title":"Oncogene"},{"key":"R66-20230829","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/rheumatology\/38.7.612","article-title":"Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis","volume":"38","author":"Hasegawa","year":"1999","journal-title":"Rheumatology"},{"key":"R67-20230829","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3899\/jrheum.120506","article-title":"Influence of the IL6 gene in susceptibility to systemic sclerosis","volume":"39","author":"C\u00e9nit","year":"2012","journal-title":"J Rheumatol"},{"key":"R68-20230829","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1582-4934.2006.tb00538.x","article-title":"The IL-6 promoter polymorphism is associated with disease activity and disability in systemic sclerosis","volume":"10","author":"Sfrent-Cornateanu","year":"2006","journal-title":"J Cell Mol Med"},{"key":"R69-20230829","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","article-title":"Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes","volume":"174","author":"De Waal Malefyt","year":"1991","journal-title":"J Exp Med"},{"key":"R70-20230829","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaci.2009.02.030","article-title":"Mechanisms and treatment of allergic disease in the big picture of regulatory T cells","volume":"123","author":"Akdis","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R71-20230829","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1399-0039.2007.00811.x","article-title":"Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis","volume":"69","author":"Beretta","year":"2007","journal-title":"Tissue Antigens"},{"key":"R72-20230829","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/sji.12020","article-title":"Interleukin-10 gene promoter and NFKB1 promoter insertion\/deletion polymorphisms in systemic sclerosis","volume":"77","author":"Salim","year":"2013","journal-title":"Scand J Immunol"},{"key":"R73-20230829","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00296-008-0594-8","article-title":"Association between \u2018interleukin\u2019 10 gene (IL10) polymorphisms and systemic sclerosis with interstitial lung involvement","volume":"28","author":"Ates","year":"2008","journal-title":"Rheumatol Int"},{"key":"R74-20230829","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1007\/s11033-012-1510-6","article-title":"Association of the interleukin-10 1082G\/A, 819C\/T and 3575T\/A gene polymorphisms with systemic sclerosis: a meta-analysis","volume":"39","author":"Peng","year":"2012","journal-title":"Mol Biol Rep"},{"key":"R75-20230829","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbrc.2008.06.054","article-title":"Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis","volume":"373","author":"Hikami","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R76-20230829","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.0105-2896.2004.00211.x","article-title":"Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4","volume":"202","author":"Watford","year":"2004","journal-title":"Immunol Rev"},{"key":"R77-20230829","first-page":"2838","article-title":"Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis","volume":"27","author":"Sato","year":"2000","journal-title":"J Rheumatol"},{"key":"R78-20230829","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajhg.2013.12.002","article-title":"Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis","volume":"94","author":"Mayes","year":"2014","journal-title":"Am J Hum Genet"},{"key":"R79-20230829","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1002\/art.38870","article-title":"Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus","volume":"66","author":"L\u00f3pez-Isac","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R80-20230829","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/hmg\/ddr522","article-title":"GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations","volume":"21","author":"Bossini-Castillo","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R81-20230829","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"J Exp Med"},{"key":"R82-20230829","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3899\/jrheum.080120","article-title":"Increased serum interleukin 23 in patients with systemic sclerosis","volume":"35","author":"Komura","year":"2008","journal-title":"J Rheumatol"},{"key":"R83-20230829","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R84-20230829","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3899\/jrheum.090421","article-title":"Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis","volume":"36","author":"Agarwal","year":"2009","journal-title":"J Rheumatol"},{"key":"R85-20230829","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.2008.096719","article-title":"The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype","volume":"68","author":"Rueda","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R86-20230829","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cell.2007.12.030","article-title":"Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4\/13 system","volume":"132","author":"LaPorte","year":"2008","journal-title":"Cell"},{"key":"R87-20230829","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm1332","article-title":"IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis","volume":"12","author":"Fichtner-Feigl","year":"2006","journal-title":"Nat Med"},{"key":"R88-20230829","first-page":"2015","article-title":"IL13RA2 gene polymorphisms are associated with systemic sclerosis","volume":"33","author":"Granel","year":"2006","journal-title":"J Rheumatol"},{"key":"R89-20230829","doi-asserted-by":"crossref","first-page":"e59842","DOI":"10.1371\/journal.pone.0059842","article-title":"BANK1 and BLK act through phospholipase C gamma 2 in B-cell signaling","volume":"8","author":"Bernal-Quir\u00f3s","year":"2013","journal-title":"PLoS One"},{"key":"R90-20230829","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.immuni.2006.01.002","article-title":"BANK negatively regulates Akt activation and subsequent B cell responses","volume":"24","author":"Aiba","year":"2006","journal-title":"Immunity"},{"key":"R91-20230829","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1002\/art.24885","article-title":"BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4","volume":"60","author":"Dieud\u00e9","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R92-20230829","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/ard.2009.118174","article-title":"BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians","volume":"69","author":"Rueda","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R93-20230829","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaut.2009.08.014","article-title":"Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations","volume":"34","author":"Gourh","year":"2010","journal-title":"J Autoimmun"},{"key":"R94-20230829","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/art.27303","article-title":"Association of the FAM167A\u2013BLK region with systemic sclerosis","volume":"62","author":"Ito","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R95-20230829","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/art.30379","article-title":"C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large French cohort and meta-analysis","volume":"63","author":"Coustet","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R96-20230829","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.4049\/jimmunol.179.7.4704","article-title":"Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes","volume":"179","author":"Rieck","year":"2007","journal-title":"J Immunol"},{"key":"R97-20230829","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1002\/art.22196","article-title":"Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis","volume":"54","author":"Gourh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R98-20230829","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","article-title":"The IRF family transcription factors in immunity and oncogenesis","volume":"26","author":"Tamura","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"R99-20230829","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"R100-20230829","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/rheumatology\/kei244","article-title":"Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients","volume":"45","author":"Tan","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R101-20230829","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/ard.2009.121400","article-title":"Type I interferon system activation and association with disease manifestations in systemic sclerosis","volume":"69","author":"Eloranta","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R102-20230829","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/art.23486","article-title":"Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis","volume":"58","author":"Kim","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R103-20230829","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24183","article-title":"Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis","volume":"60","author":"Dieud\u00e9","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R104-20230829","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/art.24600","article-title":"Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population","volume":"60","author":"Ito","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R105-20230829","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/039463201402700420","article-title":"Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese","volume":"27","author":"Wang","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R106-20230829","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3899\/jrheum.091163","article-title":"Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity","volume":"37","author":"Dieude","year":"2010","journal-title":"J Rheumatol"},{"key":"R107-20230829","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/ard.2009.118315","article-title":"Association of IRF5 polymorphisms with activation of the interferon alpha pathway","volume":"69","author":"Rullo","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R108-20230829","doi-asserted-by":"crossref","DOI":"10.1002\/art.39730","article-title":"Cross-disease meta-analysis of genome-wide association studies for systemic sclerosis and rheumatoid arthritis reveals IRF4 as a new common susceptibility locus","author":"L\u00f3pez-Isac","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R109-20230829","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/annrheumdis-2011-200275","article-title":"Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis","volume":"71","author":"Carmona","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R110-20230829","doi-asserted-by":"crossref","first-page":"e1002178","DOI":"10.1371\/journal.pgen.1002178","article-title":"Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy","volume":"7","author":"Gorlova","year":"2011","journal-title":"PLoS Genet"},{"key":"R111-20230829","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13075-015-0572-y","article-title":"Identification of NF-\u03baB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis","volume":"17","author":"Arismendi","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R112-20230829","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1471-4906(02)02222-6","article-title":"Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal?","volume":"23","author":"O\u2019Neill","year":"2002","journal-title":"Trends Immunol"},{"key":"R113-20230829","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.33325","article-title":"A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators","volume":"64","author":"Broen","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R114-20230829","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"R115-20230829","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/art.22179","article-title":"Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma","volume":"54","author":"Wu","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R116-20230829","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/rheumatology\/ker259","article-title":"Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population","volume":"50","author":"Bossini-Castillo","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R117-20230829","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.it.2005.06.004","article-title":"NLRs join TLRs as innate sensors of pathogens","volume":"26","author":"Martinon","year":"2005","journal-title":"Trends Immunol"},{"key":"R118-20230829","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2004.05.004","article-title":"Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases","volume":"117","author":"Martinon","year":"2004","journal-title":"Cell"},{"key":"R119-20230829","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/ard.2010.131243","article-title":"NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis","volume":"70","author":"Dieud\u00e9","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R120-20230829","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/sj.jid.5700953","article-title":"Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population","volume":"127","author":"Jin","year":"2007","journal-title":"J Invest Dermatol"},{"key":"R121-20230829","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/gene.2008.85","article-title":"A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes","volume":"10","author":"Magitta","year":"2009","journal-title":"Genes Immun"},{"key":"R122-20230829","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature09782","article-title":"Autophagy in immunity and inflammation","volume":"469","author":"Levine","year":"2011","journal-title":"Nature"},{"key":"R123-20230829","doi-asserted-by":"crossref","first-page":"e13932","DOI":"10.1371\/journal.pone.0013932","article-title":"Phospholipase D family member 4, a transmembrane glycoprotein with no phospholipase D activity, expressed in spleen and early postnatal microglia","volume":"5","author":"Yoshikawa","year":"2010","journal-title":"PLoS One"},{"key":"R124-20230829","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/art.37777","article-title":"PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population","volume":"65","author":"Terao","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R125-20230829","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ng.71","article-title":"A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus","volume":"40","author":"Nath","year":"2008","journal-title":"Nat Genet"},{"key":"R126-20230829","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1074\/jbc.M406968200","article-title":"Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2","volume":"280","author":"Solovjov","year":"2005","journal-title":"J Biol Chem"},{"key":"R127-20230829","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1136\/ard.2010.148874","article-title":"Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis","volume":"70","author":"Carmona","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R128-20230829","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2011.07.007","article-title":"Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases","volume":"11","author":"Anaya","year":"2012","journal-title":"Autoimmun Rev"},{"key":"R129-20230829","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3899\/jrheum.101053","article-title":"Association study of ITGAM, ITGAX, and CD58 autoimmune risk loci in systemic sclerosis: results from 2 large European Caucasian cohorts","volume":"38","author":"Coustet","year":"2011","journal-title":"J Rheumatol"},{"key":"R130-20230829","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1002\/1521-4141(200211)32:11<3326::AID-IMMU3326>3.0.CO;2-9","article-title":"Consequences of OX40\u2013OX40 ligand interactions in Langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice","volume":"32","author":"Sato","year":"2002","journal-title":"Eur J Immunol"},{"key":"R131-20230829","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard.2009.116434","article-title":"Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis","volume":"69","author":"Gourh","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R132-20230829","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.2010.141838","article-title":"A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort","volume":"70","author":"Bossini-Castillo","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R133-20230829","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ni1563","article-title":"The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20","volume":"9","author":"Shembade","year":"2008","journal-title":"Nat Immunol"},{"key":"R134-20230829","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1136\/ard.2009.127928","article-title":"Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population","volume":"69","author":"Dieud\u00e9","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R135-20230829","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/art.34490","article-title":"Candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity","volume":"64","author":"Koumakis","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R136-20230829","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/art.37777","article-title":"PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population","volume":"65","author":"Terao","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R137-20230829","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/art.39476","article-title":"Identification of an association of TNFAIP3 polymorphisms with matrix metalloproteinase expression in fibroblasts in an integrative study of systemic sclerosis-associated genetic and environmental factors","volume":"68","author":"Wei","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R138-20230829","doi-asserted-by":"crossref","first-page":"18482","DOI":"10.1074\/jbc.M601502200","article-title":"ABIN-1 binds to NEMO\/IKKgamma and co-operates with A20 in inhibiting NF-kappaB","volume":"281","author":"Mauro","year":"2006","journal-title":"J Biol Chem"},{"key":"R139-20230829","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbrc.2009.08.074","article-title":"ABIN-1 negatively regulates NF-kappaB by inhibiting processing of the p105 precursor","volume":"389","author":"Cohen","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"R140-20230829","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/373441a0","article-title":"Cell-autonomous Fas (CD95)\/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas","volume":"373","author":"Brunner","year":"1995","journal-title":"Nature"},{"key":"R141-20230829","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2007.04.031","article-title":"The CD95 receptor: apoptosis revisited","volume":"129","author":"Peter","year":"2007","journal-title":"Cell"},{"key":"R142-20230829","first-page":"2003","article-title":"Resistance to apoptosis in circulating alpha\/beta and gamma\/delta T lymphocytes from patients with systemic sclerosis","volume":"33","author":"Cipriani","year":"2006","journal-title":"J Rheumatol"},{"key":"R143-20230829","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","article-title":"Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95","volume":"43","author":"Sgonc","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R144-20230829","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/ard.2008.088989","article-title":"The \u2212670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis","volume":"68","author":"Liakouli","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R145-20230829","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/art.24964","article-title":"The FAS \u2212670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes","volume":"60","author":"Broen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R146-20230829","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc3204","article-title":"The diverse and complex roles of NF-\u03baB subunits in cancer","volume":"12","author":"Perkins","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"R147-20230829","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/hmg\/dds099","article-title":"Identification of CSK as a systemic sclerosis genetic risk factor through genome wide association study follow-up","volume":"21","author":"Martin","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R148-20230829","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/sji.12020","article-title":"Interleukin-10 gene promoter and NFKB1 promoter insertion\/deletion polymorphisms in systemic sclerosis","volume":"77","author":"Salim","year":"2013","journal-title":"Scand J Immunol"},{"key":"R149-20230829","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1359-6101(03)00049-2","article-title":"The CC chemokine CCL20 and its receptor CCR6","volume":"14","author":"Schutyser","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"R150-20230829","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1084\/jem.20071397","article-title":"Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model","volume":"204","author":"Hirota","year":"2007","journal-title":"J Exp Med"},{"key":"R151-20230829","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/mi.2008.84","article-title":"The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut","volume":"2","author":"Wang","year":"2009","journal-title":"Mucosal Immunol"},{"key":"R152-20230829","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1684\/ejd.2011.1469","article-title":"Up-regulation of CC chemokine ligand 20 and its receptor CCR6 in the lesional skin of early systemic sclerosis","volume":"21","author":"Tao","year":"2011","journal-title":"Eur J Dermatol"},{"key":"R153-20230829","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1002\/art.38136","article-title":"A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosis","volume":"65","author":"Koumakis","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R154-20230829","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0888-7543(05)80169-7","article-title":"Assignment of the genes encoding human interleukin-8 receptor types 1 and 2 and an interleukin-8 receptor pseudogene to chromosome 2q35","volume":"14","author":"Morris","year":"1992","journal-title":"Genomics"},{"key":"R155-20230829","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Ztotnik","year":"2000","journal-title":"Immunity"},{"key":"R156-20230829","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cyto.2012.05.026","article-title":"Combined effects of CXCL8 and CXCR2 gene polymorphisms on susceptibility to systemic sclerosis","volume":"60","author":"Salim","year":"2012","journal-title":"Cytokine"},{"key":"R157-20230829","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(00)70060-4","article-title":"DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes","volume":"4","author":"Shibuya","year":"1996","journal-title":"Immunity"},{"key":"R158-20230829","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/gene.2008.82","article-title":"CD226 Gly307Ser association with multiple autoimmune diseases","volume":"10","author":"Hafler","year":"2009","journal-title":"Genes Immun"},{"key":"R159-20230829","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/art.30204","article-title":"Association of the CD226Ser307 variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis","volume":"63","author":"Dieud\u00e9","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R160-20230829","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1096\/fj.02-0442fje","article-title":"Hepatocyte growth factor counteracts transforming growth factor-\u03b21, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5\/6 nephrectomized mice","volume":"17","author":"Inoue","year":"2003","journal-title":"FASEB J"},{"key":"R161-20230829","first-page":"136","article-title":"Overexpression of hepatocyte growth factor receptor in scleroderma dermal fibroblasts is caused by autocrine transforming growth factor \u03b2 signaling","volume":"6","author":"Kajihara","year":"2012","journal-title":"Biosci Trends"},{"key":"R162-20230829","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/art.30415","article-title":"Association of hepatocyte growth factor promoter polymorphism with severity of interstitial lung disease in Japanese patients with systemic sclerosis","volume":"63","author":"Hoshino","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R163-20230829","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12079-009-0068-0","article-title":"The role of osteopontin in inflammatory processes","volume":"3","author":"Lund","year":"2009","journal-title":"J Cell Commun Signal"},{"key":"R164-20230829","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/039463201402700112","article-title":"Is osteopontin involved in cutaneous fibroblast activation? Its hypothetical role in scleroderma pathogenesis","volume":"27","author":"Corallo","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R165-20230829","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.humimm.2011.06.009","article-title":"Association of osteopontin regulatory polymorphisms with systemic sclerosis","volume":"72","author":"Barizzone","year":"2011","journal-title":"Hum Immunol"},{"key":"R166-20230829","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/jid.2012.32","article-title":"Osteopontin in systemic sclerosis and its role in dermal fibrosis","volume":"132","author":"Wu","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"(Suppl A)","key":"R167-20230829","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1053\/joca.2001.0447","article-title":"L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway","volume":"9","author":"Lefebvre","year":"2001","journal-title":"Osteoarthritis Cartilage"},{"key":"R168-20230829","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1073\/pnas.101132598","article-title":"Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors","volume":"98","author":"Koontz","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R169-20230829","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1093\/hmg\/ddt248","article-title":"A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci","volume":"22","author":"Martin","year":"2013","journal-title":"Hum Mol Genet"},{"key":"R170-20230829","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/561","article-title":"Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription","volume":"19","author":"Jones","year":"1998","journal-title":"Nat Genet"},{"key":"R171-20230829","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/hmg\/ddn380","article-title":"Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism","volume":"18","author":"Swanberg","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R172-20230829","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1136\/annrheumdis-2012-202742","article-title":"New insight on the Xq28 association with systemic sclerosis","volume":"72","author":"Carmona","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R173-20230829","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.dnarep.2015.02.005","article-title":"The structural basis of XRCC1-mediated DNA repair","volume":"30","author":"London","year":"2015","journal-title":"DNA Repair (Amst)"},{"key":"R174-20230829","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1073\/pnas.1222573110","article-title":"Functional redundancy between the XLF and DNA-PKcs DNA repair factors in V(D)J recombination and nonhomologous DNA end joining","volume":"110","author":"Oksenych","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R175-20230829","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1128\/MCB.26.5.1786-1794.2006","article-title":"SUMO modification of human XRCC4 regulates its localization and function in DNA double-strand break repair","volume":"26","author":"Yurchenko","year":"2006","journal-title":"Mol Cell Biol"},{"key":"R176-20230829","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3899\/jrheum.130376","article-title":"Patients with systemic sclerosis present increased DNA damage differentially associated with DNA repair gene polymorphisms","volume":"41","author":"Palomino","year":"2014","journal-title":"J Rheumatol"},{"key":"R177-20230829","first-page":"1244","article-title":"Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon","volume":"30","author":"Porciello","year":"2003","journal-title":"J Rheumatol"},{"key":"R178-20230829","first-page":"258","article-title":"Unstabilized DNA breaks in lymphocytes of patients with systemic sclerosis","volume":"16","author":"Majone","year":"2006","journal-title":"Eur J Dermatol"},{"key":"R179-20230829","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cca.2009.06.022","article-title":"Caucasian-specific allele in non-synonymous single nucleotide polymorphisms of the gene encoding deoxyribonuclease I-like 3, potentially relevant to autoimmunity, produces an inactive enzyme","volume":"407","author":"Ueki","year":"2009","journal-title":"Clin Chim Acta"},{"key":"R180-20230829","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/ng.975","article-title":"Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus","volume":"43","author":"Al-Mayouf","year":"2011","journal-title":"Nat Genet"},{"key":"R181-20230829","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1074\/jbc.M112.423061","article-title":"Apoptotic DNA fragmentation may be a cooperative activity between caspase-activated deoxyribonuclease and the poly (ADP-ribose) polymerase-regulated DNAS1L3, and endoplasmic reticulum-localized endonuclease that translocates to the nucleus during apoptosis","volume":"288","author":"Errami","year":"2013","journal-title":"J Biol Chem"},{"key":"R182-20230829","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semarthrit.2007.10.010","article-title":"The immunobiology of systemic sclerosis","volume":"38","author":"Gu","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"R183-20230829","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/art.23436","article-title":"Src kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosis","volume":"58","author":"Skhirtladze","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R184-20230829","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1523\/JNEUROSCI.0635-05.2005","article-title":"MONaKA, a novel modulator of the plasma membrane Na,K-ATPase","volume":"25","author":"Mao","year":"2005","journal-title":"J Neurosci"},{"key":"R185-20230829","first-page":"151","article-title":"Grb10 proteins in insulin-like growth factor and insulin receptor signaling","volume":"5","author":"Morrione","year":"2000","journal-title":"Int J Mol Med"},{"key":"R186-20230829","doi-asserted-by":"crossref","first-page":"8460","DOI":"10.1074\/jbc.M208518200","article-title":"Grb10 inhibits insulin-stimulated insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase\/Akt signaling pathway by disrupting the association of IRS-1\/IRS-2 with the insulin receptor","volume":"278","author":"Wick","year":"2003","journal-title":"J Biol Chem"},{"key":"R187-20230829","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.matbio.2013.03.005","article-title":"Role of caveolin-1 in fibrotic diseases","volume":"32","author":"Gvaramia","year":"2013","journal-title":"Matrix Biol"},{"key":"R188-20230829","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/annrheumdis-2011-200986","article-title":"Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis","volume":"71","author":"Manetti","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R189-20230829","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1111\/j.1582-4934.2012.01537.x","article-title":"Elevated expression of cav-1 in a subset of SSc fibroblasts contributes to constitutive Alk1\/Smad1 activation","volume":"16","author":"Haines","year":"2012","journal-title":"J Cell Mol Med"},{"key":"R190-20230829","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/art.23791","article-title":"Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis","volume":"58","author":"Del Galdo","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R191-20230829","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1084\/jem.20061536","article-title":"Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis","volume":"203","author":"Wang","year":"2006","journal-title":"J Exp Med"},{"key":"R192-20230829","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.284.5415.770","article-title":"Notch signaling: cell fate control and signal integration in development","volume":"284","author":"Artavanis-Tsakonas","year":"1999","journal-title":"Science"},{"key":"R193-20230829","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0092-8674(85)90058-3","article-title":"A novel ras-related gene family","volume":"41","author":"Madaule","year":"1985","journal-title":"Cell"},{"key":"R194-20230829","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1034\/j.1600-0625.2003.00048.x","article-title":"Polymorphisms in the SEEK1 and SPR1 genes on 6p21.3 associate with psoriasis in the Swedish population","volume":"12","author":"Holm","year":"2003","journal-title":"Exp Dermatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201611000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T06:46:16Z","timestamp":1693291576000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201611000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":194,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000334","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}